Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02166905 |
Title | DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission |
Recruitment | Completed |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Roswell Park Cancer Institute |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |